vTv Therapeutics Inc. (VTVT) Financials
VTVT Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| March 31, 2026 | 98.8 million | 8.9 million |
| Dec. 31, 2025 | 89.9 million | 25.5 million |
| Sept. 30, 2025 | 99.5 million | 29.0 million |
| June 30, 2025 | 26.4 million | 24.0 million |
VTVT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| March 31, 2026 | 9.2 million | 1.4 million |
| Dec. 31, 2025 | -9.3 million | 1.0 million |
| Sept. 30, 2025 | -5.2 million | 1.0 million |
| June 30, 2025 | -5.1 million | 930000 |
VTVT Net Income
No data available :(
VTVT Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| March 31, 2026 | 98.1 million | - | - |
| Dec. 31, 2025 | 88.9 million | - | - |
| Sept. 30, 2025 | 98.5 million | - | 32000 |
| June 30, 2025 | 25.9 million | - | 79000 |
VTVT Shares Outstanding
VTVT Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| March 31, 2026 | - | 9.0 million | 4.6 million | - |
| Dec. 31, 2025 | - | 3.9 million | 4.0 million | - |
| Sept. 30, 2025 | - | 7.0 million | 3.7 million | - |
| June 30, 2025 | - | 4.1 million | 3.6 million | - |
VTVT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| March 31, 2026 | 36.8 million | 1000 |
| Dec. 31, 2025 | -24000 | 2000 |
| Sept. 30, 2025 | - | - |
| June 30, 2025 | - | 3000 |
VTVT
Price: $35.04
52 week price:
Earnings Per Share: -0.78 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 36900
Ebitda: -11.5 millionMarket Capitalization: 90.6 million